Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
Tools
Gao, Ya, Shi, Shuzhen, Liu, Ming, Wu, Fanqi, Zhang, Junhua, Song, Fujian and Tian, Jinhui (2021) Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer. Cochrane Database of Systematic Reviews, 2021 (10). ISSN 1361-6137
![]() |
PDF (Published_Version)
- Published Version
Restricted to Repository staff only until 19 October 2022. Request a copy |
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and safety of immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide compared with platinum-etoposide alone for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).
Item Type: | Article |
---|---|
Uncontrolled Keywords: | pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2736 |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Related URLs: | |
Depositing User: | LivePure Connector |
Date Deposited: | 06 Dec 2021 18:18 |
Last Modified: | 24 May 2022 14:42 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/82572 |
DOI: | 10.1002/14651858.CD014809 |
Actions (login required)
![]() |
View Item |